The National Comprehensive Cancer Network, American Cancer Society Cancer Action Network, and the National Minority Quality Forum have developed recommendations on how to lessen racial disparities in cancer care.
In two back-to-back, all-day meetings, the FDA Oncologic Drugs Advisory Committee considered four thorny applications that the agency appeared to have been saving up as a result of the pause in activity that followed President Trump’s return to office.
